Position in GILD
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$18,652,837
-$3,187,138 QoQ
Shares Held
147,640
-5.8% QoQ
Ownership
0.012%
of shares outstanding
% of Portfolio
1.40%
of 13F equity value
Holder Rank
#333
of 2,265 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 82%
Shared 0%
None 18%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026EDGAR LOMAX CO/VA holds $161,967,278 across 7 Drug Manufacturers - General names. GILD ranks #4 (11.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PFE |
Pfizer Inc
|
1,365,777 | $32,887,910 | |
| 2 | JNJ |
Johnson & Johnson
|
125,880 | $31,969,743 | |
| 3 | BMY |
Bristol Myers Squibb Co
|
461,275 | $26,578,665 | |
| 4 | GILD |
Gilead Sciences, Inc.
This page
|
147,640 | $18,652,837 | |
| 5 | MRK |
Merck & Co., Inc.
|
143,985 | $18,502,072 | |
| 6 | AMGN |
Amgen Inc
|
46,233 | $16,741,893 | |
| 7 | ABBV |
AbbVie Inc.
|
66,103 | $16,634,158 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $18,652,837 | 147,640 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $21,839,975 | 156,705 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $21,029,044 | 171,330 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $19,458,300 | 175,300 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $25,240,109 | 227,655 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $25,927,249 | 231,390 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $11,600,748 | 125,590 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $10,730,681 | 127,990 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $8,917,927 | 129,980 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $9,691,707 | 132,310 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $8,092,817 | 99,899 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $7,788,064 | 103,924 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $8,143,909 | 105,669 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $8,884,842 | 107,085 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $19,101,625 | 222,500 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $13,805,605 | 223,790 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $13,989,766 | 226,335 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $13,088,214 | 220,155 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $11,604,530 | 159,820 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $11,269,249 | 161,335 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $11,312,665 | 164,285 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $11,028,140 | 170,635 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $10,202,199 | 175,115 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $11,258,246 | 178,165 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $13,154,047 | 170,965 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $12,533,514 | 167,650 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||